Menu Back toDay-2-Session-5-Compliance-Management
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
"PV Fast Forward" - Technology, Pace, Priority.
Day 2 : Session 5 - Compliance Management
Mangesh Kulkarni, MD
- Head Drug Safety
- Tata Consultancy Services, India
Session 5.1: Risk Minimisation Activities & Evalution of Effectiveness
Seema Jaitly, DrMed
- Managing Director
- Essjay Solutions Ltd, United Kingdom
Sesson 5.2: A risk based approach to real time compliance
Savitha Hanuman, MPharm
- VP. Accenture Life Sciences Operations
- Accenture, India
Session 5.3 : Indian Pharmacovigilance - Where do we stand today
J Vijay Venkatraman, MD, MBA
- Managing Director and CEO
- Oviya MedSafe, India